Drug companies are being advised to familiarize themselves with the updated code of practice from the Association of the British Pharmaceutical Industry before it comes into effect on 1 October and introduces new elements, including those on how to provide prescribing information.
The new 2024 edition of the code has also moved certain elements from “guidance” to “mandatory” status, such as requiring written agreements where companies provide support to health care professionals...
Key Takeaways
-
The 2024 edition of the ABPI’s code of practice will come into effect on 1 October, but activities failing to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?